Nucleome Therapeutics
ID: 6195759Nucleome Therapeutics technology uses novel molecular biology techniques that define the 3D structure of the genome and computational genomics powered by machine learning to help deliver the next generation of genetically guided therapeutics.
1
Funding Rounds
$86.4m
Money raised
Recent Funding Rounds
Overview
Unlock Complete Company Intelligence
Access comprehensive data and insights available only to Seedtable members
Financial Details
- • Complete funding history and valuations
- • Revenue estimates and financial metrics
- • Investment round details and terms
People & Contacts
- • Complete leadership team profiles
- • Contact information and email addresses
- • Board members and advisors
Market Intelligence
- • Competitive landscape analysis
- • Market position and growth metrics
- • Industry benchmarking data
Premium Tools
- • Export data and generate reports
- • Save companies to custom watchlists
- • API access for data integration
Join 10,000+ Professionals
Trusted by investors, founders, and analysts worldwide
Access detailed insights on 71,000+ companies worldwide
Funding series
Funding Series Analysis
The company Nucleome Therapeutics has raised a total of $42.35m in funding over 1 rounds.
Key Insights:
- Nucleome Therapeutics - Series A round, October 2022: $42.35m